As of 2025-05-18, the EV/EBITDA ratio of Tekla Healthcare Opportunities Fund (THQ) is -395.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. THQ's latest enterprise value is 978.12 mil USD. THQ's TTM EBITDA according to its financial statements is -2.47 mil USD. Dividing these 2 quantities gives us the above THQ EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 23.1x | 18.5x |
| Forward P/E multiples | 17.0x - 23.0x | 18.7x |
| Fair Price | (6.47) - (6.81) | (6.55) |
| Upside | -135.6% - -137.4% | -136.0% |
| Date | EV/EBITDA |
| 2025-05-16 | -395.96 |
| 2025-05-15 | -390.10 |
| 2025-05-14 | -390.10 |
| 2025-05-13 | -396.63 |
| 2025-05-12 | -407.02 |
| 2025-05-09 | -396.97 |
| 2025-05-08 | -399.98 |
| 2025-05-07 | -403.84 |
| 2025-05-06 | -404.84 |
| 2025-05-05 | -413.38 |
| 2025-05-02 | -414.39 |
| 2025-05-01 | -410.03 |
| 2025-04-30 | -416.57 |
| 2025-04-29 | -417.74 |
| 2025-04-28 | -413.05 |
| 2025-04-25 | -411.04 |
| 2025-04-24 | -408.19 |
| 2025-04-23 | -404.67 |
| 2025-04-22 | -404.51 |
| 2025-04-21 | -399.82 |
| 2025-04-17 | -407.86 |
| 2025-04-16 | -410.70 |
| 2025-04-15 | -413.05 |
| 2025-04-14 | -412.71 |
| 2025-04-11 | -408.36 |
| 2025-04-10 | -400.99 |
| 2025-04-09 | -410.37 |
| 2025-04-08 | -390.77 |
| 2025-04-07 | -391.78 |
| 2025-04-04 | -404.34 |
| 2025-04-03 | -428.29 |
| 2025-04-02 | -432.65 |
| 2025-04-01 | -431.14 |
| 2025-03-31 | -436.84 |
| 2025-03-28 | -433.82 |
| 2025-03-27 | -431.14 |
| 2025-03-26 | -430.47 |
| 2025-03-25 | -433.82 |
| 2025-03-24 | -443.87 |
| 2025-03-21 | -438.68 |
| 2025-03-20 | -439.35 |
| 2025-03-19 | -440.86 |
| 2025-03-18 | -436.50 |
| 2025-03-17 | -438.85 |
| 2025-03-14 | -430.97 |
| 2025-03-13 | -429.13 |
| 2025-03-12 | -432.98 |
| 2025-03-11 | -433.32 |
| 2025-03-10 | -439.52 |
| 2025-03-07 | -444.21 |